InvestorsHub Logo

PennyWorld

04/26/22 7:52 PM

#855 RE: Joe Kaplan #854

If it is true that the FDA is waiting for the completion of the NIH trial before making a decision on EUA, then unfortunately we may easily see this drift down well below a buck because for all practical purposes NRXP has nothing else of value (IMO) in their pipeline. JMHO